Clinical trial Recruiting at 1 site Observational

Monitoring and improving hypertension management in Xinjiang

Official title: Prognostic Model of Hypertension

Run by Xinjiang Medical University · NCT06160921 · Data updated 2026-11-12

This study is trying to improve how people with high blood pressure are treated in Xinjiang by tracking their health and treatment over ten years to find better ways to manage their condition.

Quick facts

Study typeObservational
SexAll
Enrollment50000 (estimated)
SponsorXinjiang Medical University
Academic / other
Locations1 site (Ürümqi, Xinjiang)
StatusRecruiting
StartedJanuary 1, 2020
Main results expectedJanuary 1, 2030
Study endsJanuary 1, 2030
Registry record updatedMarch 28, 2024
Trial IDNCT06160921 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with primary hypertension who are admitted to the First Affiliated Hospital of Xinjiang Medical University.

Probably not a fit

Patients with secondary hypertension, liver and kidney dysfunction, mental disorders, or those unwilling to participate will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a comprehensive registration and monitoring system for patients with hypertension in Xinjiang from 2020 to 2030. It will collect real-world data on patient characteristics, treatment patterns, hospitalization outcomes, and complications associated with hypertension. The study seeks to develop effective treatment strategies and prevention guidelines to optimize patient management and reduce morbidity and mortality related to hypertension. By creating a platform for clinical research and translational medicine, the study aims to enhance the quality of care for hypertension patients in the region.

Why it matters

Potential benefit: If successful, this study could lead to improved management and outcomes for patients with hypertension.

How similar studies have gone: While similar observational studies have been conducted, this specific approach in Xinjiang is novel and aims to address local healthcare needs.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University

Exclusion Criteria:

* Patients with secondary hypertension, patients with liver and kidney dysfunction,
* patients with mental disorders, and patients who are unwilling to participate in this trial

Where it's running

  • The First Affiliated Hospital of Xinjiang Medicial University
    Ürümqi, Xinjiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.